CTNM

NASDAQ:CTNM

Contineum Therapeutics

  • Stock

USD

Last Close

11.01

06/11 21:00

Market Cap

541.73M

Beta: -

Volume Today

132.52K

Avg: -

PE Ratio

−20.64

PFCF: −17.65

OverviewFinancialsAPI
Income StatementBalance SheetCash FlowKey MetricsRatios
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '21
Dec '22
Dec '23
net income
-29.00M
-
-24.25M
16.37%
22.72M
193.68%
depreciation and amortization
325K
-
329K
1.23%
195K
40.73%
deferred income tax
stock based compensation
1.75M
-
1.93M
10.18%
2.22M
15.15%
change in working capital
108K
-
-1.27M
1,273.15%
-1.02M
19.18%
accounts receivables
inventory
accounts payables
-110K
-
-230K
109.09%
other working capital
218K
-
-1.04M
575.69%
-1.02M
1.25%
other non cash items
164K
-
5.96M
3,532.93%
-2.15M
136.12%
net cash provided by operating activities
-26.27M
-
-20.12M
23.40%
19.35M
196.16%
investments in property plant and equipment
-168K
-
-118K
29.76%
-414K
250.85%
acquisitions net
purchases of investments
-66.78M
-
-64.70M
3.11%
-141.87M
119.27%
sales maturities of investments
1.98M
-
87.12M
4,308.70%
76.71M
11.94%
other investing activites
-64.80M
-
22.42M
134.59%
-65.15M
390.65%
net cash used for investing activites
-64.97M
-
22.30M
134.32%
-65.57M
394.04%
debt repayment
-1.25M
-
-3.75M
200%
common stock issued
15K
-
59.95M
399,593.33%
common stock repurchased
-4K
-
-28K
600%
dividends paid
other financing activites
79.84M
-
15K
99.98%
-343K
2,386.67%
net cash used provided by financing activities
79.84M
-
-1.24M
101.55%
56.18M
4,633.98%
effect of forex changes on cash
net change in cash
-11.39M
-
939K
108.24%
9.96M
960.38%
cash at beginning of period
16.02M
-
4.63M
71.11%
5.57M
20.28%
cash at end of period
4.63M
-
5.57M
20.28%
15.53M
178.79%
operating cash flow
-26.27M
-
-20.12M
23.40%
19.35M
196.16%
capital expenditure
-168K
-
-118K
29.76%
-414K
250.85%
free cash flow
-26.43M
-
-20.24M
23.44%
18.93M
193.56%

All numbers in USD (except ratios and percentages)